Reporting of adverse drug events: a key to postmarketing drug safety

Am Fam Physician. 1992 Sep;46(3):873-4.

Author

P H Rheinstein¹

Affiliation

¹ U.S. Food and Drug Administration, Rockville, Maryland.

PMID: 1514478

No abstract available

MeSH terms

Adverse Drug Reaction Reporting Systems*
Humans
Product Surveillance, Postmarketing
United States
United States Food and Drug Administration*